- Forums
- ASX - By Stock
- SNT
- Ann: Interim data in Phase 2 study of SNT-5505 in myelofibrosis
SNT
syntara limited
Add to My Watchlist
14.9%
!
5.7¢

Ann: Interim data in Phase 2 study of SNT-5505 in myelofibrosis, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.7¢ |
Change
-0.010(14.9%) |
Mkt cap ! $97.48M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 5.7¢ | $448.4K | 7.489M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 485979 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 21249 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 719981 | 0.057 |
4 | 467200 | 0.056 |
7 | 786068 | 0.055 |
2 | 225780 | 0.054 |
2 | 82266 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 294916 | 8 |
0.061 | 143290 | 2 |
0.062 | 82319 | 2 |
0.064 | 48000 | 1 |
0.065 | 211115 | 5 |
Last trade - 14.00pm 16/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |